Andrew Hill Investment Advisors Inc. Boosts Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Andrew Hill Investment Advisors Inc. grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 6.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 4,269 shares of the biotechnology company’s stock after buying an additional 254 shares during the quarter. Axon Enterprise makes up approximately 1.9% of Andrew Hill Investment Advisors Inc.’s portfolio, making the stock its 25th largest holding. Andrew Hill Investment Advisors Inc.’s holdings in Axon Enterprise were worth $2,537,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in AXON. Vanguard Group Inc. lifted its position in Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock valued at $5,019,886,000 after purchasing an additional 275,959 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Axon Enterprise by 3.7% in the 4th quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company’s stock valued at $1,095,542,000 after purchasing an additional 65,097 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock valued at $659,128,000 after purchasing an additional 812,337 shares during the last quarter. Norges Bank acquired a new position in shares of Axon Enterprise during the 4th quarter valued at $482,081,000. Finally, GQG Partners LLC purchased a new position in Axon Enterprise in the 4th quarter valued at about $478,349,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 11.1 %

Shares of NASDAQ AXON opened at $559.84 on Thursday. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm’s 50 day simple moving average is $571.11 and its two-hundred day simple moving average is $558.24. The stock has a market capitalization of $42.90 billion, a P/E ratio of 144.66, a PEG ratio of 5.17 and a beta of 1.13.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Needham & Company LLC restated a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Finally, Barclays reiterated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $604.67.

Insider Activity

In related news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.